Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyotaka Izumi

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|June 23, 2026
Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specifiedTomoya Kitagawa, Kiyotaka Izumi, Katsuhiro Io
IEEE Transactions on Systems, Man, and Cybernetics. Part B, Cybernetics : a Publication of the IEEE Systems, Man, and Cybernetics Society|September 17, 2004
Modular fuzzy-neuro controller driven by spoken language commandsKoliya Pulasinghe, Keigo Watanabe, Kiyotaka Izumi, et al.
Journal of the American Chemical Society|November 23, 2012
Anomalous reactivity of silylborane: transition-metal-free boryl substitution of aryl, alkenyl, and alkyl halides with silylborane/alkoxy base systemsEiji Yamamoto, Kiyotaka Izumi, Yuko Horita, et al.
International Journal of Clinical Oncology|October 15, 2015
Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapyFutoshi Iioka, Kiyotaka Izumi, Yoshimasa Kamoda, et al.
International Journal of Hematology|February 12, 2025
Efficacy and safety of the thiotepa-busulfan conditioning regimen as for autologous stem cell transplantation in relapsed/refractory systemic diffuse large B cell lymphoma: a single-center retrospective studyKatsuhiro Io, Kenichi Nagai, Bunta Kakihara, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 13, 2016
Direct Introduction of a Dimesitylboryl Group Using Base-Mediated Substitution of Aryl Halides with SilyldimesitylboraneEiji Yamamoto, Kiyotaka Izumi, Ryosuke Shishido, et al.
Genes, Chromosomes & Cancer|April 30, 2020
Establishment and characterization of a MALT lymphoma cell line carrying an API2-MALT1 translocationKiyotaka Izumi, Momoko Nishikori, Hepei Yuan, et al.
Molecular Immunology|January 22, 2020
EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomasYasuyuki Otsuka, Momoko Nishikori, Hiroshi Arima, et al.
Blood Cell Therapy|June 8, 2026
Successful allogeneic stem cell transplantation for a patient with high titers of donor-specific antibody after multiple desensitization proceduresKiyotaka Izumi, Kazuki Yoshioka, Yuto Ueda, et al.
Blood Advances|September 15, 2018
B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33Hiroshi Arima, Momoko Nishikori, Yasuyuki Otsuka, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|June 23, 2026
Single-agent gemcitabine enabling successful bridging to allogeneic haematopoietic stem-cell transplantation in refractory peripheral T-cell lymphoma, not otherwise specifiedTomoya Kitagawa, Kiyotaka Izumi, Katsuhiro Io
IEEE Transactions on Systems, Man, and Cybernetics. Part B, Cybernetics : a Publication of the IEEE Systems, Man, and Cybernetics Society|September 17, 2004
Modular fuzzy-neuro controller driven by spoken language commandsKoliya Pulasinghe, Keigo Watanabe, Kiyotaka Izumi, et al.
Journal of the American Chemical Society|November 23, 2012
Anomalous reactivity of silylborane: transition-metal-free boryl substitution of aryl, alkenyl, and alkyl halides with silylborane/alkoxy base systemsEiji Yamamoto, Kiyotaka Izumi, Yuko Horita, et al.
International Journal of Clinical Oncology|October 15, 2015
Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapyFutoshi Iioka, Kiyotaka Izumi, Yoshimasa Kamoda, et al.
International Journal of Hematology|February 12, 2025
Efficacy and safety of the thiotepa-busulfan conditioning regimen as for autologous stem cell transplantation in relapsed/refractory systemic diffuse large B cell lymphoma: a single-center retrospective studyKatsuhiro Io, Kenichi Nagai, Bunta Kakihara, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 13, 2016
Direct Introduction of a Dimesitylboryl Group Using Base-Mediated Substitution of Aryl Halides with SilyldimesitylboraneEiji Yamamoto, Kiyotaka Izumi, Ryosuke Shishido, et al.
Genes, Chromosomes & Cancer|April 30, 2020
Establishment and characterization of a MALT lymphoma cell line carrying an API2-MALT1 translocationKiyotaka Izumi, Momoko Nishikori, Hepei Yuan, et al.
Molecular Immunology|January 22, 2020
EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomasYasuyuki Otsuka, Momoko Nishikori, Hiroshi Arima, et al.
Blood Cell Therapy|June 8, 2026
Successful allogeneic stem cell transplantation for a patient with high titers of donor-specific antibody after multiple desensitization proceduresKiyotaka Izumi, Kazuki Yoshioka, Yuto Ueda, et al.
Blood Advances|September 15, 2018
B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33Hiroshi Arima, Momoko Nishikori, Yasuyuki Otsuka, et al.
Pageof 2